Search results
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 3 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on ...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 2 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Exploring Shark Tank India fame Anupam Mittal’s lifestyle: From luxurious 6 BHK house to swanky cars
Pinkvilla· 5 days agoShark Tank India is one of its own kind of shows on national television. While Shark Tank India has...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 3 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
A New Ray of Hope: Cannazo India's Breakthrough in Medical Cannabis for Multiple Sclerosis on Shark ...
SiliconIndia· 3 days agoIn 2023, the Asia-Pacific region (which includes India) contributed to 33% of the global hemp...
Emcure Pharma IPO Day 2: Check Subscription Status, GMP Today - News18
News18· 10 hours agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which was opened for...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 1 day agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 3 hours agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Ambey Laboratories IPO price band set at ₹65-68 per share; SME IPO to open on July 4 | Stock Market...
Livemint· 2 days agoAmbey Laboratories IPO price band has been fixed at ₹65 - ₹68 per share. Ambey Laboratories IPO is...
Emcure Pharmaceuticals IPO booked nearly 3x so far on Day 2. Check GMP and other details
The Economic Times· 6 hours agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked nearly three times so far on...